Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38169
CAS Number:
915967-82-7
Tetrafosfato de piperaquina tetrahidratado
Purity:
≥ 98 % (HPLC)
Synonym(s):
Tetrahidrato de 1,3-bis[4-(7-cloroquinolin-4-il)piperazin-1-il]propanotetrafosfato, 7-Cloro-4-[4-[3-[4-(7-cloroquinolin-4-il)piperazin-1-il]propil]piperazin-1-il]quinolina
Documents
$1,849.27 /5G
Tamaño
Request Bulk Quote
Información del producto

Conservar bajo gas inerte.

Número CAS
915967-82-7
Fórmula molecular
C29H32Cl2N6 · 4H3PO4 · 4H2O
Peso molecular
999.55
Número MDL
MFCD11870901
Punto de fusión
252 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
915967-82-7
Fórmula molecular
C29H32Cl2N6 · 4H3PO4 · 4H2O
Peso molecular
999.55
Número MDL
MFCD11870901
Punto de fusión
252 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Piperaquine tetraphosphate tetrahydrate is widely utilized in research focused on:

  • Antimalarial Treatments: This compound is primarily used in combination therapies for malaria, enhancing the efficacy of existing treatments and helping to combat drug resistance.
  • Pharmaceutical Development: It serves as a key ingredient in the formulation of new antimalarial drugs, allowing researchers to explore its synergistic effects with other compounds.
  • Clinical Research: Piperaquine tetraphosphate tetrahydrate is involved in clinical trials aimed at evaluating its safety and effectiveness in various populations, providing valuable data for healthcare professionals.
  • Vector Control Studies: The compound is also studied for its potential in controlling malaria vectors, contributing to broader public health strategies aimed at reducing malaria transmission.
  • Drug Formulation Innovations: Its unique properties facilitate the development of advanced drug delivery systems, improving the bioavailability and therapeutic outcomes of antimalarial medications.

Citas